standard and alternative dosing regimens of immunotherapies and combinations in modern oncology
Published 3 years ago • 290 plays • Length 26:32
Download video MP4
Download video MP3
Similar videos
-
33:06
maximizing the of potential current and emerging immunotherapies in advanced endometrial cancer
-
1:25:42
navigating immunotherapies and combinations in the search for the best strategy for each patient
-
28:23
biomarkers, immunotherapies, combinations, and other emerging approaches for lung cancer
-
56:08
gaining confidence in predicting and assessing response to cancer immunotherapies
-
1:01:58
essential conversations for hcc: radiology-oncology collaboration and immunotherapy advances
-
1:05:53
cancer immunotherapy beyond 2020
-
1:29:06
leveraging neoadjuvant and adjuvant immunotherapy to improve outcomes in early-stage cancers
-
38:09
understanding and working with new immunotherapeutic and targeted management models in advanced rcc
-
39:06
expanding the benefits of immuno-oncology through novel rational targets and combinations
-
0:32
dr. hak choy on radiation and immunotherapy in combination in lung cancer
-
1:50:50
emerging biomarkers, new targets, and rational combinations in immuno-oncology
-
54:59
linking immunotherapy to better outcomes in resectable melanoma
-
57:18
translating progress with immunotherapies and targeted agents into improved outcomes in tnbc
-
1:03:39
deep insight into immuno-oncology: immunotherapy pathways, targets, and biomarkers
-
1:33:59
revisiting pd-l1 as an immunotherapy biomarker across the cancer spectrum
-
59:06
gastric and gej cancers: treatment planning and sequencing in the era of immunotherapy
-
1:36:33
strengthening our grip on immuno-oncology in genitourinary cancers
-
1:31:04
immunotherapy for sclc and the "four ps" in managed care—patient, provider, pharmacy, and plan
-
1:03:49
making the most of the new era of immuno-oncology in tnbc: essential guidance for surgeons
Clip.africa.com - Privacy-policy